Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)

Data Collection Analysis Business Management

Status: Unknown

Conditions: Pharmacogenomic

Treatments: Genetic: pharmacogenomic

Study type: Observational

Funder types: Other

Identifiers

NCT03322189

PAS1463

Details and patient eligibility

About

Current providers' standard operating procedures on pharmacogenomic testing patients

Full description

The general design of this study is collecting data and reviewing Principal Investigators' Standard Operating Procedures on Pharmacogenomic testing and changes made to their specific SOP.

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 64 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Must be a Medical Practitioner

  • Medical Doctor (MD)
  • Doctor of Osteopathic (DO)
  • Physician Assistant (PA)
  • Advanced Practice Registered Nurse (APRN)
  • Nurse Practioner (NP)

• Must have a current standard operating procedure that includes obtaining/reviewing medical history.

Exclusion criteria

• Government-funded insurance data cannot be included in the study.